No profile data available.
Cellyan Biotechnology Co., Ltd (HKPD) is an essential consumer products company in the medication retail outlets industry, based in Yau Tong, Hong Kong, with about 11 full-time employees.
It reported revenue of $13.43 million for fiscal year 2026, down 33.9% from fiscal year 2025, and net income of -$1.14 million. Its market capitalization was $5.52 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2026; market data as of October 9, 2026.
, Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services.
Cellyan Biotechnology reported $13.43 million in revenue for fiscal year 2026, down 33.9% from $20.31 million in fiscal year 2025.
$5.52 million as of October 9, 2026.
Listed companies of a similar size in the same industry (medication retail outlets) include Rest EZ INC (RTEZ), NextPlat Corp (NXPL), Polomar Health Services, Inc. (PMHS), Relevium Technologies Inc. (RLLVF).